برای نمایش بهتر وب سایت از ورژن جدید مرورگر فایرفاکس یا گوگل کروم استفاده نمایید.

دانلود ورژن جدید فایرفاکس دانلود ورژن جدید کروم
English فارسی
logo

مرکز تحقیقات کلیه Kidney Research Center

فهرست اصلی

مقاله های سال ۲۰۱۹

  1. Mortazavi H, Soltani‐Zangbar MS, Eghbal‐Fard S, Mehdizadeh A, Kamrani A, Chakeri‐Khiavi F, Kafil HS, Jadidi‐Niaragh F, Rahimifar S, Khosroshahi HT, Yousefi M. Cytokine profile, Treg/Th۱۷ cell frequency changes during different posttransplantational time points in patients undergoing renal transplantation. Journal of cellular physiology. ۲۰۱۹ Nov;۲۳۴(۱۱):۲۰۹۳۵-۴۳.

  2. Bastami M, Choupani J, Saadatian Z, Zununi Vahed S, Ouladsahebmadarek E, Mansoori Y, Daraei A, Samadi Kafil H, Yousefi B, Mahdipour M, Masotti A. Evidences from a systematic review and meta-analysis unveil the role of miRNA polymorphisms in the predisposition to female neoplasms. International journal of molecular sciences. ۲۰۱۹ Jan;۲۰(۲۰):۵۰۸۸.

  3. Saadat YR, Pourseif MM, Vahed SZ, Barzegari A, Omidi Y, Barar J. Modulatory role of vaginal-isolated lactococcus lactis on the expression of miR-۲۱, miR-۲۰۰b, and TLR-۴ in CAOV-۴ cells and in silico revalidation. Probiotics and Antimicrobial Proteins. ۲۰۲۰ Sep;۱۲(۳):۱۰۸۳-۹۶.

  4. Sharifi S, Samani AA, Ahmadian E, Eftekhari A, Derakhshankhah H, Jafari S, Mokhtarpour M, Vahed SZ, Salatin S, Dizaj SM. Oral delivery of proteins and peptides by mucoadhesive nanoparticles. Biointerface Research in Applied Chemistry. ۲۰۱۹;۹(۲):۳۸۴۹-۵۲.

  5. Sharifi S, Vahed SZ, Ahmadian E, Dizaj SM, Eftekhari A, Khalilov R, Ahmadi M, Hamidi-Asl E, Labib M. Detection of pathogenic bacteria via nanomaterials-modified aptasensors. Biosensors and Bioelectronics. ۲۰۲۰ Feb ۱۵;۱۵۰:۱۱۱۹۳۳.

  6. Eftekhari A, Hasanzadeh A, Khalilov R, Hosainzadegan H, Ahmadian E, Eghbal MA. Hepatoprotective role of berberine against paraquat-induced liver toxicity in rat. Environmental Science and Pollution Research. ۲۰۲۰ Feb;۲۷(۵):۴۹۶۹-۷۵.

  7. Vahed SZ, Ardalan M, Ronco C. Rein cardiaque: Historical Notes on Cardiorenal Syndrome. Cardiorenal medicine. ۲۰۱۹;۹(۶):۳۳۷-۴۰.

  8. Vahed SZ, Rikhtegar E, Attari VE, Haghi M, Tolouian R, Shojas MM, Ardalan M. APOL۱ renal risk alleles in patients on chronic hemodialysis in Northwest of Iran.

  9. ZUNUNI VAHED S, ARDALAN M, KHALILOV R, AHMADIAN E. Betanin prohibits cisplatin-induced nephrotoxicity through targeting mitochondria. Marmara Pharmaceutical Journal. ۲۰۱۹ Nov ۱;۲۳(۶).

  10. Dizaj SM, Rad AA, Safaei N, Salatin S, Ahmadian E, Sharifi S, Vahed SZ, Lotfipour F, Shahi S. The Application of Nanomaterials in Cardiovascular Diseases: A Review on Drugs and Devices. Journal of Pharmacy & Pharmaceutical Sciences. ۲۰۱۹ Oct ۷;۲۲:۵۰۱-۱۵.

  11. Sharifi S, Zununi Vahed S, Ahmadian E, Maleki Dizaj S, Abedi A, Hosseiniyan Khatibi SM, Samiei M. Stem cell therapy: Curcumin does the trick. Phytotherapy Research. ۲۰۱۹ Nov;۳۳(۱۱):۲۹۲۷-۳۷.

  12. Amiri, P., Baradaran, B., Saghafi-Asl, M., Naghizadeh, M., Shanehbandi, D., Karamzad, N. and Vahed, S.Z., ۲۰۱۹. Association of proinflammatory genes expression with serum interleukin ۱β and free fatty acids in metabolically healthy and unhealthy abdominally obese individuals: a case-control study. BMC immunology, ۲۰(۱), p.۲۳.

  13. Nakhjavani, M., Etemadi, J., Pourlak, T., Mirhosaini, Z., Vahed, S.Z. and Abediazar, S., ۲۰۱۹. Plasma levels of miR-۲۱, miR-۱۵۰, miR-۴۲۳ in patients with lupus nephritis. Iranian journal of kidney diseases, ۱۳(۳), p.۱۹۸.

  14. Vahed SZ, Sani HM, Haghi M, Shoja MM, Ardalan M. TRPC۶ and NPHS۲ gene variants in adult patients with steroid-resistant nephrotic syndrome in North-West of Iran. Molecular Biology Reports. ۲۰۱۹ Dec ۱;۴۶(۶):۶۳۳۹-۴۴.

  15. Saleh, P., Hosseini, M.S., Piri, R., Ghaffari, M., Mohammadi, S. and Naghavi-Behzad, M., ۲۰۱۹. Association of lung cancer and tuberculosis: A cross sectional study from northwest of Iran. International Journal of Cancer Management, ۱۲(۶), p.e۸۹۹۱۵.

  16. Motavalli R, Etemadi J, Kahroba H, Mehdizadeh A, Yousefi M. Immune system-mediated cellular and molecular mechanisms in idiopathic membranous nephropathy pathogenesis and possible therapeutic targets. Life sciences. ۲۰۱۹ Dec ۱;۲۳۸:۱۱۶۹۲۳.

  17. Bavand, A., Aghakhani, A., Mohraz, M., Banifazl, M., Karami, A., Golkar, M., Babaie, J., Saleh, P., Mamishi, S. and Ramezani, A., ۲۰۱۹. Prevalence of Toxoplasma gondii Antibodies and DNA in Iranian HIV Patients. Iranian Journal of Pathology, ۱۴(۱), p.۶۸.

  18. Nouri-Vaskeh M, Sadeghifard S, Saleh P, Farhadi J, Amraii M, Ansarin K. Vitamin D Deficiency among Patients with Tuberculosis: a Cross-Sectional Study in Iranian-Azari Population. Tanaffos. ۲۰۱۹ Jan;۱۸(۱):۱۱.

  19. Vahed SZ, Sani HM, Rajabzadeh S, Nariman-Saleh-Fam Z, Hejazian M, Vahed FZ, Khatibi SM, Shoja MM, Ardalan M. The importance of genetic study in steroid-resistant nephrotic syndrome. Journal of Renal Injury Prevention. ۲۰۱۹ Sep ۱۳;۸(۴):۲۷۱-۸۲.

  20. Sani HM, Vahed SZ, Ardalan M. Preeclampsia: a close look at renal dysfunction. Biomedicine & Pharmacotherapy. ۲۰۱۹ Jan ۱;۱۰۹:۴۰۸-۱۶.

  21. Saadat YR, Hejazian M, Bastami M, Khatibi SM, Ardalan M, Vahed SZ. The role of microbiota in the pathogenesis of lupus: Dose it impact lupus nephritis?. Pharmacological Research. ۲۰۱۹ Jan ۱;۱۳۹:۱۹۱-۸.

  22. Nakhjavani MR, Abediazar S, Ghorbanihaghjo A, Hanafizadeh B, Vahed SZ, Pourlak T. The importance of serum neutrophil gelatinase-associated lipocalin level in patients with lupus nephritis. Journal of Renal Injury Prevention. ۲۰۱۹ Jun;۸(۲):۱۳۳-۹.

  23. Jafari-Nakhjavani M, Ghorbanihaghjo A, Pourghassem E, Abediazar S, Pourlak T, Malekmahdavi A. Serum pentraxin ۳ levels in rheumatoid arthritis patients and its association with disease activity. The Egyptian Rheumatologist. ۲۰۱۹ Oct ۱;۴۱(۴):۲۵۱-۴.

  24. Hashemi SS, Navarbaf Z, Ghorbanihaghjo A, Ghojazadeh M, Etemadi J, Abediazar S. Parathyroid hormone or fibroblast growth factor ۲۳? Which one is the main determinant of the hypophosphatemia after kidney transplantation?. Journal of Renal Injury Prevention. ۲۰۱۸ Oct ۳۰;۸(۲):۸۶-۹۰.

  25. Etemadi J, Motavalli R, Mahmoodpoor F, Abediazar S. Elevated levels of plasma microRNA-۱۹۲ in patients with lupus nephritis. Immunopathologia Persa. ۲۰۱۹ Jan ۲۹;۵(۱):e۰۲-.

  26. Khatibi SM, Vahed FZ, Sharifi S, Ardalan M, Shoja MM, Vahed SZ. Osmolytes resist against harsh osmolarity: Something old something new. Biochimie. ۲۰۱۹ Mar ۱;۱۵۸:۱۵۶-۶۴.

  27. Nakhjavani, M., Abediazar, S., Ghorbanihaghjo, A., Esmaeili, N., Pourlak, T. and Vahed, S.Z., ۲۰۱۹. Serum tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) and IL-۱۷ levels are associated with disease activity in systemic lupus erythematosus patients with and without nephritis. Journal of Renal Injury Prevention, ۸(۳), pp.۲۰۴-۲۱۰.

  28. Nakhjavani, M.R.J., Ghorbanihaghjo, A., Asadollahipour, O.D., Azar, S.A., Pourlak, T. and Mahdavi, A.M., ۲۰۱۹. Correlation Between Serum Cartilage Oligomeric Matrix Protein (COMP), ۲۵-Hydroxy Vitamin D, and Disease Activity in Patients with Knee Osteoarthritis. Iranian Red Crescent Medical Journal, ۲۱(۵).

  29. Esfandiari, A., B. Pourghassem Gargari, H. Noshad, P. Sarbakhsh, M. Mobasseri, M. Barzegari, and P. Arzhang. "The effects of vitamin D۳ supplementation on some metabolic and inflammatory markers in diabetic nephropathy patients with marginal status of vitamin D: A randomized double blind placebo controlled clinical trial." Diabetes & Metabolic Syndrome: Clinical Research & Reviews ۱۳, no. ۱ (۲۰۱۹): ۲۷۸-۲۸۳.

  30. Noshad H, Ghorbani R, Herizchi S, Shayan SK, Ghamari B, Shayan FK. Sertraline prevents hypotension during hemodialysis: A randomized clinical trial. Nephro-Urology Monthly. ۲۰۱۸(In Pre).

  31. Boostani K, Noshad H, Farnood F, Rezaee H, Teimouri S, Entezari-Maleki T, Najafiazar R, Hassanpouri-Olia A, Gharekhani A. Detection and management of common medication errors in internal medicine wards: impact on medication costs and patient care. Advanced pharmaceutical bulletin. ۲۰۱۹ Feb;۹(۱):۱۷۴.

  32. Mardomi A, Mohammadi N, Khosroshahi HT, Abediankenari S. An update on potentials and promises of T cell co‐signaling molecules in transplantation. Journal of cellular physiology. ۲۰۲۰ May;۲۳۵(۵):۴۱۸۳-۹۷.

  33. Laffin, M.R., Tayebi Khosroshahi, H., Park, H., Laffin, L.J., Madsen, K., Kafil, H.S., Abedi, B., Shiralizadeh, S. and Vaziri, N.D., ۲۰۱۹. Amylose resistant starch (HAM‐RS۲) supplementation increases the proportion of Faecalibacterium bacteria in end‐stage renal disease patients: Microbial analysis from a randomized placebo‐controlled trial. Hemodialysis International, ۲۳(۳), pp.۳۴۳-۳۴۷.

  34. Barzegari, M., Sarbakhsh, P., Mobasseri, M., Noshad, H., Esfandiari, A., Khodadadi, B. and Gargari, B.P., ۲۰۱۹. The effects of vitamin D supplementation on lipid profiles and oxidative indices among diabetic nephropathy patients with marginal vitamin D status. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, ۱۳(۱), pp.۵۴۲-۵۴۷.

  35. Hekmatshoar Y, Saadat YR, Khatibi SM, Ozkan T, Vahed FZ, Nariman-Saleh-Fam Z, Gargari BP, Sunguroglu A, Vahed SZ. The impact of tumor and gut microbiotas on cancer therapy: Beneficial or detrimental?. Life sciences. ۲۰۱۹ Sep ۱۵;۲۳۳:۱۱۶۶۸۰.